A treatment trial of acupuncture in IBS patients

American Journal of Gastroenterology

Volumn 104, Issue 6, 2009, Pages 1489-1497

  Lembo, Anthony J ^a,f   Conboy, Lisa ^b   Kelley, John M ^c,d   Schnyer, Rosa S ^b   McManus, Claire A ^b   Quilty, Mary T ^b   Kerr, Catherine E ^b   Drossman, Doug ^b   Jacobson, Eric E ^e   Davis, Roger B ^b   Kaptchuk, Ted J ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d ENDICOTT COLLEGE   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUPUNCTURE; ADULT; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOCTOR PATIENT RELATION; FEMALE; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PALLIATIVE THERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ACUPUNCTURE THERAPY; ADULT; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; PATIENT SATISFACTION; PHYSICIAN-PATIENT RELATIONS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 67349162156     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.156     Document Type: Article

References (47)

1. Longstreth GF, Thompson WG, Chey WD et al. Functional bowel disorders. Gastroenterology 2006;130:1480-9.
2. Saito YA, Schoenfeld P, Locke GR III. The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol 2002;97:1910-5.
3. Gralnek IM, Hays RD, Kilbourne A et al. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 2000;119:654-60.
4. Maxion-Bergemann S, Thielecke F, Abel F et al. Costs of irritable bowel syndrome in the UK and US. Pharmacoeconomics 2006;24:21-37.
5. Inadomi JM, Fennerty MB, Bjorkman D. Systematic review: the economic impact of irritable bowel syndrome. Aliment Pharmacol Ther 2003;8: 671-82.
6. Hussain Z, Quigley EM. Systematic review: complementary and alternative medicine in the irritable bowel syndrome. Aliment Pharmacol Ther 2006;23:465-7.
7. Kong SC, Hurlstone DP, Pocock CY et al. The incidence of self-prescribed oral complementary and alternative medicine use by patients with gastrointestinal diseases. J Clin Gastroenterol 2005;39:138-41.
8. Kaptchuk TJ. Acupuncture: theory, efficacy and practice. Ann Intern Med 2002;136:374-83.
9. Xiao WB, Liu YL. Rectal hypersensitivity reduced by acupoint TENS in patients with diarrhea-predominant irritable bowel syndrome: a pilot study. Dig Dis Sci 2004;49:312-9.
10. Cui KM, Li WM, Gao X et al. Electro-acupuncture relieves chronic visceral hyperalgesia in rats. Neurosci Lett 2005;376:20-3.
11. Tillisch K. Complementary and alternative medicine for functional gastrointestinal disorders. Gut 2006;55:593-6.
12. Lim B, Manheimer E, Lao L et al. Acupuncture for treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2006 , October 18: CD005111.
13. Schneider A, Enck P, Streitberger K et al. Acupuncture treatment in irritable bowel syndrome. Gut 2006;55:649-54.
14. Chassany O, Marquis P, Scherrer B et al. Validation of a specific quality of life questionnaire for functional digestive disorders. Gut 1999;44:527-33.
15. Kaptchuk TJ, Kelley JM, Conboy LA et al. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ 2008;336:999-1003.
16. Chin Feman SP, Nguyen LT, Quilty MT et al. Efectiveness of recruitment in clinical trials: an analysis of methods used in a trial for irritable bowel syndrome patients. Contemp Clin Trials 2008;29:241-51.
17. Thompson WG, Longstreth GF, Drossman DA et al. Functional bowel disorders and functional abdominal pain. Gut 1999;45 (Suppl 2):II43-7.
18. Vanner SJ, Depew WT, Paterson WG et al. Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome. Am J Gastroenterol 1999;94:2912-7.
19. Hammer J, Eslick GD, Howell SC et al. Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia. Gut 2004;53:666-72.
20. Schnyer RN, Allen JJ. Bridging the gap in complementary and alternative medicine research: manualization as a means of promoting standardization and flexibility of treatment in clinical trials of acupuncture. J Altern Complement Med 2002;8:623-34.
21. Kong J, Gollub R, Huang T et al. Acupuncture de qi, from qualitative history to quantitative measurement. J Altern Complement Med 2007;13:1059-70.
22. Streitberger K, Kleinhenz J. Introducing a placebo needle into acupuncture research. Lancet 1998;352:364-5.
23. McManus CA, Schnyer RN, Kong J et al. Sham acupuncture devices -practical advice for researchers. Acupunct Med 2007;25:36-40.
24. McManus CA, Kaptchuk TJ, Schnyer RN et al. Experiences of acupuncturists in a placebo-controlled, randomized clinical trial. J Altern Complement Med 2007;13:533-8.
25. Lembo T, Wright RA, Bagby B et al. Alosetron controls bowel urgency and provides global symptom improvement in women with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol 2001;96:2662-70.
26. Gordon S, Ameen V, Bagby B et al. Validation of irritable bowel syndrome Global Improvement Scale: an integrated symptom end point for assessing treatment efficacy. Dig Dis Sci 2003;48:1317-23.
27. Mangel AW. Personal view: adequate relief as a primary endpoint in irritable bowel syndrome. Aliment Pharmacol Ther 2006;23:879-81.
28. Mangel AW, Hahn BA, Heath AT et al. Adequate relief as an endpoint in clinical trials in irritable bowel syndrome. J Int Med Res 1998;26:76-81.
29. Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997;11:395-402.
30. Drossman DA, Morris CB, Hu Y et al. Characterization of health related quality of life for patients with functional bowel disorders and its response to treatment. Am J Gastroenterol 102:1442-53.
31. Drossman DA, Patrick DL, Whitehead WE et al. Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire. Am J Gastroenterol 2000;95:999-1007.
32. Camilleri M, Northcutt AR, Kong S et al. Effcacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial. Lancet 2000;355:1035-40.
33. Leventer SM, Raudibaugh K, Frissora CL et al. Clinical trial: dextofisopam in the treatment of patients with diarrhoea-predominant or alternating irritable bowel syndrome. Aliment Pharmacol Ther 2008;27:97-206.
34. Patrick DL, Drossman DA, Frederick IO et al. Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig Dis Sci 1998;43:400-1.
35. Brinkhaus B, Witt CM, Jena S et al. Acupuncture in patients with chronic low back pain: a randomized controlled trial. Arch Intern Med 2006;166:450-7.
36. Melchart D, Streng A, Hoppe A et al. Acupuncture in patients with tension-type headache: randomised controlled trial. BMJ 2005;33:376-82.
37. Diener HC, Kronfeld K, Boewing G et al. Effcacy of acupuncture for the prophylaxis of migraine: a multicentre randomised controlled clinical trial. Lancet Neurol 2006;5:310-6.
38. Linde K, Streng A, Jurgens S et al. Acupuncture for patients with migraine: a randomized controlled trial. JAMA 2005;293:2118-25.
39. Scharf HP, Mansmann U, Streitberger K et al. Acupuncture and knee osteoarthritis: a three-armed randomized trial. Ann Intern Med 2006;145:12-20.
40. Witt CM, Jena S, Brinkhaus B et al. Acupuncture in patients with osteoarthritis of the knee or hip: a randomized, controlled trial with an additional nonrandomized arm. Arthritis Rheum 2006;54:3485-93.
41. Witt CM, Jena S, Selim D et al. Pragmatic randomized trial evaluating the clinical and economic effectiveness of acupuncture for chronic low back pain. Am J Epidemiol 2006;164:487-96.
42. Willich SN, Reinhold T, Selim D et al. Cost-efectiveness of acupuncture treatment in patients with chronic neck pain. Pain 2006;125:107-13.
43. Lee S, Walker JR, Jakul L et al. Does elimination of placebo responders in a placebo run-in increase the treatment effect in randomized clinical trials? A meta-analytic evaluation. Depress Anxiety 2004;19:10-9.
44. Trivedi MH, Rush H. Does a placebo run-in or a placebo treatment cell affect the efficacy of antidepressant medications? Neuropsychopharmacol-ogy 1994;11:33-43.
45. Tan S, Tillisch K, Bolus SR et al. Traditional Chinese medicine based subgrouping of irritable bowel syndrome patients. Am J Chin Med 2005;33:365-79.
46. Hammerschlag R. Methodological and ethical issues in clinical trials of acupuncture. J Altern Complement Med 1998;4:159-71.
47. Schneider A, Weiland C, Enck P et al. Neuroendocrinological effects of acupuncture treatment in patients with irritable bowel syndrome. Complement Ther Med 2007;15:255-63.